Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...

Emerging opportunities include advancements in mRNA and viral vector technologies for rapid development, improved distribution through digital tracking, and public-private partnerships enhancing ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...

Messenger RNA vaccines have proven to be effective and are safer than standard vaccines, because they have fewer side effects; also, since viruses tend to mutate, updated mRNA vaccines can be produced ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

NIH director Jay Bhattacharya has offered a new explanation for why the federal government canceled $500 million in contracts ...

Canceling federal mRNA vaccine projects threatens much more than pandemic response, an expert at Michigan State University ...

A detailed picture of what happens when DNA transcription is paused early in the process has been obtained by structural ...